Richard Gaynor - 16 Jun 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Seth A. Tasker as attorney-in-fact for Richard Gaynor, M.D.
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 20:43:00 UTC
Previous filing
16 Jun 2022
Next filing
08 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +45,000 $0.000000 45,000 16 Jun 2022 Common Stock 45,000 $0.6790 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.

Remarks:

Exhibit 24 - Limited Power of Attorney